Skip to main content
Upadacitinib shows a favorable benefit-risk profile in adolescents with moderate-to-severe atopic dermatitis
Primary tabs
•••
View
Get Stamp Tags
Published Locations
Breadcrumb
Home
Upadacitinib shows a favorable benefit-risk profile in adolescents with moderate-to-severe atopic dermatitis
User login
Username
Password
Reset your password
Concept
Lead
score
Dermatitis
1
1
Adolescent Medicine
0
1
Atopic Dermatitis
0
1
Topical Corticosteroid
0
0.16
Corticosteroids
0
0.11
Eczema
0
0.11
Severity Index
0
0.11
Specialty
Lead
score
Dermatology
1
1
Family Medicine/Primary Care
0
1
Pediatrics
0
1
Edit Tags